Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PL BioScience Names Summit Pharmaceuticals as Exclusive Japan Distributor | Contract Pharma

What are you searching for?

Sign in
Breaking News

PL BioScience Names Summit Pharmaceuticals as Exclusive Japan Distributor

Summit Pharmaceuticals to distribute PL BioScience’s ELAREM Ultimate-FD PLUS and broader ELAREM portfolio for clinical applications.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

PL BioScience GmbH, a German manufacturer of Human Platelet Lysate used in cell therapy and regenerative medicine, has signed an exclusive distribution agreement with Summit Pharmaceuticals International Corp. for the Japanese market.

Under the arrangement, Summit Pharmaceuticals will distribute PL BioScience’s ELAREM Ultimate-FD PLUS, a GMP‑grade platelet lysate product, along with the company’s broader ELAREM portfolio for clinical applications. The companies said the partnership is intended to streamline procurement for Japanese customers and accelerate the adoption of qualified raw materials in early-stage development.

“We are excited to team up with SPI as this distribution agreement lays the groundwork for PL BioScience’s expansion into the Japanese market,” said Jungsoo Park, VP of Marketing and Sales, PL BioScience. “We believe there is a strong alignment between the two companies and shared values of high-quality products and customer support.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics